Sector: Healthcare|Industry: Medical Devices|Market Cap: $42.94B|Employees: 19.8K
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. The company is a pioneer in heart valve therapies, offering both surgical and transcatheter solutions. They also provide hemodynamic monitoring systems used in hospitals, and are focused on expanding into less invasive mitral and tricuspid valve therapies.
Highlights not available for this filing.
We're currently processing this filing. Would you like to be notified when the highlights are ready?